Skip to main content
. 2021 Apr 12;12:652383. doi: 10.3389/fimmu.2021.652383

Table 3.

Analysis of the phenotype of lymphocytes in PJP and non-PJP patients.

  PJP patients (n = 40) non-PJP patients (n = 40) *P-Value
Age (years) 52 (23-73) 49 (39-60) 0.383
Males, n% 26 (65) 26 (65) 0.258
Lymphocyte subsets
 CD28+ CD4+ T cells (%) 83.74 (32.91-99.50) 90.18 (83.27-97.08) 0.243
 CD28+CD8+ T cells (%) 40.42 (23.6157.22) 57.99 (37.74-78.24) 0.079
 HLA-DR+CD3+ T cells (%) 32.14 (16.46-71.84) 24.64 (11.69-27.79) 0.400
 HLA-DR+CD8+ T cells (%) 65.02 (41.85-88.19) 46.22 (27.79-64.65) 0.079
 CD45RA+CD4+ T cells (%) 25.86 (9.22-42.50) 30.80 (8.44-53.17) 0.841
 CD45RO+CD4+ T cells (%) 74.14 (57.50-90.78) 69.20 (46.86-91.55) 0.842
 CD4+CD25+CD127- cells (%) 2.58 (1.06-4.09) 2.75 (1.11-4.40) 0.905
 CD45RA+ Treg cells (%) 0.37 (0.10-0.63) 0.33 (0.11-1.93) 0.497
 CD45RO+ Treg cells (%) 2.21 (0.87-3.55) 2.02 (0.84-3.21) 0.661

PJP, Pneumocystis jiroveci pneumonia; *Comparisons were performed between PJP group and non-PJP group using Mann-Whitney U test chi-square test. Data are presented as number (percentage), means ± SD, or medians (2.5th - 97.5th centiles).